HEADER TRANSFERASE/TRANSFERASE INHIBITOR 09-AUG-12 4GJ2 TITLE TYK2 (JH1) IN COMPLEX WITH 2,6-DICHLORO-N-[2-({[(1R,2R)-2- TITLE 2 FLUOROCYCLOPROPYL]CARBONYL}AMINO)PYRIDIN-4-YL]BENZAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 696-1022; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TYK2 GENE; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE, ATP BINDING, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.H.ULTSCH REVDAT 3 13-SEP-23 4GJ2 1 REMARK SEQADV REVDAT 2 26-JUN-13 4GJ2 1 JRNL REVDAT 1 29-MAY-13 4GJ2 0 JRNL AUTH J.LIANG,A.VAN ABBEMA,M.BALAZS,K.BARRETT,L.BEREZHKOVSKY, JRNL AUTH 2 W.BLAIR,C.CHANG,D.DELAROSA,J.DEVOSS,J.DRISCOLL,C.EIGENBROT, JRNL AUTH 3 N.GHILARDI,P.GIBBONS,J.HALLADAY,A.JOHNSON,P.B.KOHLI,Y.LAI, JRNL AUTH 4 Y.LIU,J.LYSSIKATOS,P.MANTIK,K.MENGHRAJANI,J.MURRAY,I.PENG, JRNL AUTH 5 A.SAMBRONE,S.SHIA,Y.SHIN,J.SMITH,S.SOHN,V.TSUI,M.ULTSCH, JRNL AUTH 6 L.C.WU,Y.XIAO,W.YANG,J.YOUNG,B.ZHANG,B.Y.ZHU,S.MAGNUSON JRNL TITL LEAD OPTIMIZATION OF A 4-AMINOPYRIDINE BENZAMIDE SCAFFOLD TO JRNL TITL 2 IDENTIFY POTENT, SELECTIVE, AND ORALLY BIOAVAILABLE TYK2 JRNL TITL 3 INHIBITORS. JRNL REF J.MED.CHEM. V. 56 4521 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23668484 JRNL DOI 10.1021/JM400266T REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.04 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 3 NUMBER OF REFLECTIONS : 11448 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.050 REMARK 3 FREE R VALUE TEST SET COUNT : 596 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.63 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.86 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2603 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2212 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2416 REMARK 3 BIN R VALUE (WORKING SET) : 0.2188 REMARK 3 BIN FREE R VALUE : 0.2526 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.18 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 187 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2335 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 94 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.22 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.94540 REMARK 3 B22 (A**2) : 1.33740 REMARK 3 B33 (A**2) : -2.28280 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.313 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.576 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.888 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2425 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3288 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 835 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 53 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 353 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2425 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 295 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2762 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.41 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.94 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|890 - A|916 } REMARK 3 ORIGIN FOR THE GROUP (A): -4.5871 -16.2749 -8.6795 REMARK 3 T TENSOR REMARK 3 T11: -0.0236 T22: -0.1207 REMARK 3 T33: -0.1248 T12: 0.0508 REMARK 3 T13: -0.0002 T23: 0.0317 REMARK 3 L TENSOR REMARK 3 L11: 3.8716 L22: 0.7797 REMARK 3 L33: 4.6384 L12: -0.6337 REMARK 3 L13: 1.1497 L23: -0.2404 REMARK 3 S TENSOR REMARK 3 S11: 0.0312 S12: -0.2396 S13: 0.0546 REMARK 3 S21: 0.0762 S22: 0.0937 S23: -0.1224 REMARK 3 S31: 0.0252 S32: 0.0045 S33: -0.1248 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { A|917 - A|1017 } REMARK 3 ORIGIN FOR THE GROUP (A): -11.8296 -7.2120 -11.5627 REMARK 3 T TENSOR REMARK 3 T11: -0.0494 T22: -0.0982 REMARK 3 T33: -0.0826 T12: -0.0358 REMARK 3 T13: -0.0066 T23: 0.0281 REMARK 3 L TENSOR REMARK 3 L11: 1.1374 L22: 2.3333 REMARK 3 L33: 1.9899 L12: -0.9690 REMARK 3 L13: 0.3662 L23: -0.5481 REMARK 3 S TENSOR REMARK 3 S11: 0.0134 S12: -0.2191 S13: -0.0494 REMARK 3 S21: 0.3277 S22: 0.1217 S23: 0.0898 REMARK 3 S31: 0.1671 S32: 0.0819 S33: -0.1352 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { A|1018 - A|1076 } REMARK 3 ORIGIN FOR THE GROUP (A): -10.5446 7.1988 -11.9761 REMARK 3 T TENSOR REMARK 3 T11: -0.0756 T22: -0.0219 REMARK 3 T33: -0.0847 T12: 0.0143 REMARK 3 T13: -0.0065 T23: 0.0190 REMARK 3 L TENSOR REMARK 3 L11: 1.9569 L22: 5.0894 REMARK 3 L33: 1.1752 L12: 0.5150 REMARK 3 L13: -0.7268 L23: 0.0932 REMARK 3 S TENSOR REMARK 3 S11: 0.0010 S12: -0.1880 S13: 0.1631 REMARK 3 S21: 0.3091 S22: -0.0004 S23: 0.0443 REMARK 3 S31: -0.1066 S32: 0.0958 S33: -0.0006 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { A|1077 - A|1177 } REMARK 3 ORIGIN FOR THE GROUP (A): -12.9656 12.7102 -24.7836 REMARK 3 T TENSOR REMARK 3 T11: -0.0548 T22: -0.0631 REMARK 3 T33: -0.0573 T12: 0.0083 REMARK 3 T13: 0.0158 T23: 0.0128 REMARK 3 L TENSOR REMARK 3 L11: 1.8555 L22: 1.0437 REMARK 3 L33: 0.3777 L12: -0.3016 REMARK 3 L13: 0.4207 L23: -0.0824 REMARK 3 S TENSOR REMARK 3 S11: 0.0197 S12: 0.0796 S13: 0.1124 REMARK 3 S21: -0.0493 S22: -0.0691 S23: 0.1009 REMARK 3 S31: -0.0227 S32: 0.0145 S33: 0.0494 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4GJ2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000074245. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-APR-12 REMARK 200 TEMPERATURE (KELVIN) : 173 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : SIDE SCATTERING BENT CUBE-ROOT I REMARK 200 -BEAM SINGLE CRYSTAL; ASYMMETRIC REMARK 200 CUT 4.965 DEGS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11482 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 37.040 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.48900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3NZ0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-25%(W/V) PEG3350 AND 0.2M MG REMARK 280 SULFATE, 0.1M MES PH6.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 18.07450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.00450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.03850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.00450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 18.07450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.03850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 882 REMARK 465 GLY A 883 REMARK 465 SER A 884 REMARK 465 PRO A 885 REMARK 465 ALA A 886 REMARK 465 SER A 887 REMARK 465 ASP A 888 REMARK 465 PRO A 889 REMARK 465 HIS A 1178 REMARK 465 HIS A 1179 REMARK 465 HIS A 1180 REMARK 465 HIS A 1181 REMARK 465 HIS A 1182 REMARK 465 HIS A 1183 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 971 -10.52 68.84 REMARK 500 SER A 994 95.49 -68.09 REMARK 500 ASN A1023 46.95 -159.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0XH A 1201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4GIH RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH CMP 46 REMARK 900 RELATED ID: 4GII RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH CMP 19 REMARK 900 RELATED ID: 4GI3 RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH CMP 35 REMARK 900 RELATED ID: 4GVJ RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH ADENOSINE DI-PHOSPHATE DBREF 4GJ2 A 885 1176 UNP P29597 TYK2_HUMAN 885 1176 SEQADV 4GJ2 MET A 882 UNP P29597 EXPRESSION TAG SEQADV 4GJ2 GLY A 883 UNP P29597 EXPRESSION TAG SEQADV 4GJ2 SER A 884 UNP P29597 EXPRESSION TAG SEQADV 4GJ2 ALA A 936 UNP P29597 CYS 936 ENGINEERED MUTATION SEQADV 4GJ2 ALA A 969 UNP P29597 GLN 969 ENGINEERED MUTATION SEQADV 4GJ2 ALA A 971 UNP P29597 GLU 971 ENGINEERED MUTATION SEQADV 4GJ2 ALA A 972 UNP P29597 LYS 972 ENGINEERED MUTATION SEQADV 4GJ2 ASN A 1023 UNP P29597 ASP 1023 ENGINEERED MUTATION SEQADV 4GJ2 ALA A 1142 UNP P29597 CYS 1142 ENGINEERED MUTATION SEQADV 4GJ2 ARG A 1177 UNP P29597 EXPRESSION TAG SEQADV 4GJ2 HIS A 1178 UNP P29597 EXPRESSION TAG SEQADV 4GJ2 HIS A 1179 UNP P29597 EXPRESSION TAG SEQADV 4GJ2 HIS A 1180 UNP P29597 EXPRESSION TAG SEQADV 4GJ2 HIS A 1181 UNP P29597 EXPRESSION TAG SEQADV 4GJ2 HIS A 1182 UNP P29597 EXPRESSION TAG SEQADV 4GJ2 HIS A 1183 UNP P29597 EXPRESSION TAG SEQRES 1 A 302 MET GLY SER PRO ALA SER ASP PRO THR VAL PHE HIS LYS SEQRES 2 A 302 ARG TYR LEU LYS LYS ILE ARG ASP LEU GLY GLU GLY HIS SEQRES 3 A 302 PHE GLY LYS VAL SER LEU TYR CYS TYR ASP PRO THR ASN SEQRES 4 A 302 ASP GLY THR GLY GLU MET VAL ALA VAL LYS ALA LEU LYS SEQRES 5 A 302 ALA ASP ALA GLY PRO GLN HIS ARG SER GLY TRP LYS GLN SEQRES 6 A 302 GLU ILE ASP ILE LEU ARG THR LEU TYR HIS GLU HIS ILE SEQRES 7 A 302 ILE LYS TYR LYS GLY CYS CYS GLU ASP ALA GLY ALA ALA SEQRES 8 A 302 SER LEU GLN LEU VAL MET GLU TYR VAL PRO LEU GLY SER SEQRES 9 A 302 LEU ARG ASP TYR LEU PRO ARG HIS SER ILE GLY LEU ALA SEQRES 10 A 302 GLN LEU LEU LEU PHE ALA GLN GLN ILE CYS GLU GLY MET SEQRES 11 A 302 ALA TYR LEU HIS ALA GLN HIS TYR ILE HIS ARG ASN LEU SEQRES 12 A 302 ALA ALA ARG ASN VAL LEU LEU ASP ASN ASP ARG LEU VAL SEQRES 13 A 302 LYS ILE GLY ASP PHE GLY LEU ALA LYS ALA VAL PRO GLU SEQRES 14 A 302 GLY HIS GLU TYR TYR ARG VAL ARG GLU ASP GLY ASP SER SEQRES 15 A 302 PRO VAL PHE TRP TYR ALA PRO GLU CYS LEU LYS GLU TYR SEQRES 16 A 302 LYS PHE TYR TYR ALA SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 A 302 THR LEU TYR GLU LEU LEU THR HIS CYS ASP SER SER GLN SEQRES 18 A 302 SER PRO PRO THR LYS PHE LEU GLU LEU ILE GLY ILE ALA SEQRES 19 A 302 GLN GLY GLN MET THR VAL LEU ARG LEU THR GLU LEU LEU SEQRES 20 A 302 GLU ARG GLY GLU ARG LEU PRO ARG PRO ASP LYS CYS PRO SEQRES 21 A 302 ALA GLU VAL TYR HIS LEU MET LYS ASN CYS TRP GLU THR SEQRES 22 A 302 GLU ALA SER PHE ARG PRO THR PHE GLU ASN LEU ILE PRO SEQRES 23 A 302 ILE LEU LYS THR VAL HIS GLU LYS TYR ARG HIS HIS HIS SEQRES 24 A 302 HIS HIS HIS HET 0XH A1201 26 HETNAM 0XH 2,6-DICHLORO-N-[2-({[(1R,2R)-2- HETNAM 2 0XH FLUOROCYCLOPROPYL]CARBONYL}AMINO)PYRIDIN-4- HETNAM 3 0XH YL]BENZAMIDE FORMUL 2 0XH C16 H12 CL2 F N3 O2 FORMUL 3 HOH *94(H2 O) HELIX 1 1 HIS A 893 ARG A 895 5 3 HELIX 2 2 GLY A 937 THR A 953 1 17 HELIX 3 3 LEU A 986 LEU A 990 1 5 HELIX 4 4 GLY A 996 GLN A 1017 1 22 HELIX 5 5 PRO A 1064 TYR A 1068 5 5 HELIX 6 6 ALA A 1069 LYS A 1074 1 6 HELIX 7 7 TYR A 1080 THR A 1096 1 17 HELIX 8 8 SER A 1103 GLY A 1113 1 11 HELIX 9 9 MET A 1119 ARG A 1130 1 12 HELIX 10 10 PRO A 1141 TRP A 1152 1 12 HELIX 11 11 GLU A 1155 ARG A 1159 5 5 HELIX 12 12 THR A 1161 ARG A 1177 1 17 SHEET 1 A 6 VAL A 891 PHE A 892 0 SHEET 2 A 6 TYR A 962 ASP A 968 1 O CYS A 965 N PHE A 892 SHEET 3 A 6 SER A 973 GLU A 979 -1 O VAL A 977 N LYS A 963 SHEET 4 A 6 GLU A 925 LEU A 932 -1 N LYS A 930 O LEU A 976 SHEET 5 A 6 GLY A 909 TYR A 916 -1 N TYR A 914 O VAL A 927 SHEET 6 A 6 LEU A 897 GLU A 905 -1 N ARG A 901 O LEU A 913 SHEET 1 B 3 GLY A 984 SER A 985 0 SHEET 2 B 3 VAL A1029 ASN A1033 -1 O LEU A1031 N GLY A 984 SHEET 3 B 3 LEU A1036 ILE A1039 -1 O LYS A1038 N LEU A1030 SHEET 1 C 2 TYR A1019 ILE A1020 0 SHEET 2 C 2 LYS A1046 ALA A1047 -1 O LYS A1046 N ILE A1020 SHEET 1 D 2 TYR A1054 ARG A1056 0 SHEET 2 D 2 LYS A1077 TYR A1079 -1 O PHE A1078 N TYR A1055 SITE 1 AC1 16 ARG A 901 LEU A 903 GLY A 904 GLU A 905 SITE 2 AC1 16 VAL A 911 ALA A 928 GLU A 979 TYR A 980 SITE 3 AC1 16 VAL A 981 PRO A 982 GLY A 984 ARG A1027 SITE 4 AC1 16 ASN A1028 LEU A1030 GLY A1040 HOH A1327 CRYST1 36.149 74.077 106.009 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027663 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013499 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009433 0.00000